Risankizumab treatment is associated with low and consistent infection rates over time in patients with moderate to severe psoriasis: Analysis of pooled clinical trial data

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Journal of the American Academy of Dermatology

Abbreviated Title: Journal of the American Academy of Dermatology

Publisher: Elsevier BV

ISSN (Print): 01909622

Publication date Created: October 2019

Publication date (Print): October 2019

Volume: 81

Issue: 4

Page: AB267

Article

DOI: 10.1016/j.jaad.2019.06.1169

SO-VID: a4664e62-e0f4-4d0a-b017-276fc425955b

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.